Richard Woodman compensation by year
Traws Pharma Summary Compensation Table · all 2 fiscal years held| Component | FY2019 | FY2020 |
|---|---|---|
| Salary | $375,000 | $393,750 |
| Bonus | $18,740 | $99,750 |
| Stock awards | $0 | $55,854 |
| Option awards | $20,000 | $0 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $11,572 | $2,171 |
| Total | $425,312 | $551,525 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. DEF 14A filed May 28, 2021, accession 0001104659-21-074323, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Traws Pharma, Inc. filed document, accession 0001104659-21-074323. Every figure is read from that document and cited to the page and table it appears in. Filed May 28, 2021.
Equity holdings
unvested awards at FY2020 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 639 | — | $87.75 |
| Option | 3,558 | — | $4.65 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Traws Pharma, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.
Traws Pharma’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Manoj Maniar | Senior Vice President, Product Development | $1,178,491 |
| Steven Fruchtman | President and Chief Executive Officer | $1,031,823 |
| Mark Guerin | Chief Financial Officer | $622,109 |
| Richard Woodman · this page | Chief Medical Officer and Senior Vice President, Research and Development | $551,525 |
The full Traws Pharma compensation record
free company briefThis page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.